GH — Guardant Health, Inc.

—
Nasdaq · Health Care · Health Care Providers & Services · CIK 1576280 ·
Last close
$143.28
Market Cap
$19.38B
52W High
$191.05
52W Low
$74.55
ADV30
2,078,678
Next earnings
2026-11-05

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 360,975,000 236,153,000 -132,765,000 -124,362,000 1,885,642,000 1,026,848,000 2,161,544,000
Jun 2026 334,978,000 219,029,000 -129,118,000 -120,142,000 1,912,294,000 1,053,469,000 2,135,161,000
Mar 2026 301,665,000 196,746,000 -121,350,000 -112,075,000 1,915,291,000 989,291,000 2,096,364,000
Dec 2025 281,266,000 181,774,000 -120,805,000 -128,494,000 2,013,659,000 378,203,000 2,112,966,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-185,187,000
Investing CF
$-118,526,000
Financing CF
$737,796,000
CapEx
$-55,537,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-3.49
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-3,226,729,000
Inventory
$105,463,000
Receivables
$144,249,000
ST Investments
$0
EBIT TTM
$-449,654,000
Pretax Income TTM
$-454,470,000
Interest Exp TTM
$4,816,000
Analysts
25

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,278,883,968
EBITDA
$-464,692,000
Free Cash Flow
$-60,536,124
Enterprise Value
$21,075,181,568
Total Cash
$1,026,848,000
Total Debt
$1,691,433,984
Shares Out
135,285,975
Trailing EPS
$-3.68
Book Value
$-2.05
ROE
—
ROA
-19.9%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 982,021,000 -437,248,000 -416,277,000 2,013,659,000 2,112,966,000 -99,307,000 -184,760,000
Dec 2024 739,016,000 -443,594,000 -436,373,000 1,485,609,000 1,625,256,000 -139,647,000 -239,858,000
Dec 2023 563,948,000 -564,725,000 -479,449,000 1,786,421,000 1,627,737,000 158,684,000 -324,975,000
Dec 2022 449,538,000 -544,378,000 -654,588,000 1,609,985,000 1,549,805,000 60,180,000 -309,463,000

TTM Snapshot

Revenues TTM
$1,183,105,000
NetIncome TTM
$-453,436,000
OpCashFlow TTM
—
Assets (Latest)
$1,912,294,000
Forward EPS
$-0.41

Max Pain — expiry 2027-01-15

max pain strike: $160.00 · spot: $145.14 · call oi: 4,571 · put oi: 4,305
Expected Move to 2027-01-15: ±$25.66 (17.68%) — implied range $119.48 – $170.80 · ATM straddle on $145.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
THC TENET HEALTHCARE CORP $22.45B $282.07 —
BTSG BrightSpring Health Services, Inc. $13.90B $69.83 —
EHC Encompass Health Corp $13.53B $137.88 —
DGX QUEST DIAGNOSTICS INC $28.29B $256.35 —
LH LABCORP HOLDINGS INC. $29.90B $368.24 —

News headlines (Yahoo Finance, 1h cache)

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-11-13 21:05 · Yahoo
Guardant Health Prices $500 Million Convertible Senior Notes Offering
2026-11-12 06:09 · Yahoo
Could You Have Seen The Run In Guardant Health Stock Coming?
2026-11-11 21:34 · Yahoo
Guardant Health Announces Proposed $500.0 Million Offering of Convertible Senior Notes Due 2032
2026-11-11 21:17 · Yahoo
Guardant Health Introduces New Epigenomic Applications Providing Deeper Insights for Treatment Selection with Guardant360® Liquid
2026-11-11 13:46 · Yahoo
Guardant360® Tissue Receives MOHW LDTS approval in Taiwan
2026-11-11 04:00 · Yahoo
PRECISION Study Published in ESMO Open Highlights Utility of Guardant360® Liquid and Guardant Reveal® to Assess Recurrence Risk After Surgery for Colorectal Cancer Metastases
2026-11-10 21:05 · Yahoo
Guardant Health to Participate in Upcoming Investor Conferences
2026-11-09 21:30 · Yahoo
GH Q3 2026 deep dive: new product launches and coverage wins drive growth, but market cautious on profitability
2026-11-09 10:05 · Yahoo
This cancer-testing stock is BTIG’s top pick after another major earnings beat
2026-11-09 02:38 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.